Introducing GPMed

Austrian Society for Pharmaceutical Medicine

GPMed connects professionals from the fields of medicine, science, industry, government agencies, and other institutions involved in the clinical development of pharmaceuticals.

As a scientific forum, we promote professional exchange as well as the education, training, and continuing professional development of our members.

Unser Ziel ist es, Qualität weiterzuentwickeln und Österreich als Standort für klinische Prüfungen nachhaltig zu stärken – im Interesse der Patientinnen und Patienten.

Training Sessions 2026

26.3.2026, 15 Uhr HS2
Research at MUW – New Projects and Buildings

21.5.2026, 13 Uhr HS3
BASG Discussion – Clinical Trials in Transition: The EU Biotech Act, CTIS, and What’s Next?

22.10.2026
Details folgen

26.11.2026
Details folgen

NEWS

GPMed’s statement on EU Biotech Act

GPMed’s statement on EU Biotech Act

,

GPMed welcomes the EU Biotech Act as an important step toward strengthening Europe’s position in global life sciences. The proposed framework aims to reduce regulatory barriers, accelerate innovation, and improve the translation of scientific discoveries into real-world healthcare solutions. For Austria and the wider EU, the Act represents a timely opportunity to create a more competitive, efficient, and innovation-friendly environment for clinical research and biotechnology.

Read more

Why not sign up for our GPMedium?

You'll receive announcements about our upcoming training sessions and a report on our last one (German only)